Ascendis Pharma AS (ASND)
136.24
-1.50
(-1.09%)
USD |
NASDAQ |
Dec 20, 16:00
136.20
-0.04
(-0.03%)
After-Hours: 20:00
Ascendis Pharma Total Liabilities (Quarterly): 1.330B for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Novo Nordisk AS | 41.48B |
| Evaxion Biotech AS | 15.18M |
| Trinity Biotech PLC | 123.79M |
| Akari Therapeutics PLC | 9.428M |
| Biodexa Pharmaceuticals PLC | 6.628M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.222B |
| Shareholders Equity (Quarterly) | -108.70M |
| Debt to Equity Ratio | -8.104 |
| Current Ratio | 1.161 |
| Net Debt Paydown Yield | -0.74% |